UBIMOTIF Network

The core of the research will take place in the research groups (beneficiaries) while our partners will provide value to the network and training program through secondments, mentorship, transferable skills training and expertise.

Research groups (Beneficiaries)

Petra Beli, Institute of Molecular Biology in Mainz, Germany
Helena Danielson, Beactica AB, Sweden
Norman Davey, Institute of Cancer Research, UK
Stefano Gianni, University of Rome La Sapienza, Italy
Ylva Ivarsson, Uppsala University, Sweden
Anton Khmelinskii, Institute of Molecular Biology in Mainz, Germany
Yogesh Kulathu, University of Dundee, UK
Reet Kurg, University of Tartu, Estonia
Niels Mailand, University of Copenhagen Denmark
Jakob Nilsson, University of Copenhagen, Denmark
Anders Bach, University of Copenhagen, Denmark
Matthias Peter, ETH Zürich, Switzerland
Ora Schueler-Furman, The Hebrew University of Jerusalem, Israel

Partners

Markus Queisser, GlaxoSmithKline, UK
Carlos Fontes, NZYTech Ltd, Portugal
Farid El Oualid, UbiQ BIO BV, The Netherlands
Stephan Pritz, BIOSYNTAN GmbH, Germany
Erik Jurgons, Intavis, Germany
Sašo Kocevar, hfp Consulting, Germany

Scientific Advisory Board

Helen Walden, University of Glasgow, UK
Katrin Rittinger, Francis Crick Institute, UK
Toby Gibson, EMBL, Heidelberg Germany

Ombudsman

Ari Helenius, Emeritus Professor ETH Zurich, Switzerland